Churchill Management’s Privia Health PRVA Stock Holding History

Churchill Management’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-89,714	Closed	-$3.06M	–	132
2022 Q3	$3.06M	Buy	+89,714	New	+$3.32M	0.08%	101

Other funds holding PRVA

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Churchill Management's PRVA Position: Q4 2022 in Review

Churchill Management sold out of Privia Health (PRVA) in Q4 2022, closing a stake of 89,714 shares — an estimated $3.06M sold.

Churchill Management first reported a position in PRVA in Q3 2022 and held it in 1 quarter. The position peaked at $3.06M in Q3 2022. 192 funds tracked by Wall St. Rank hold PRVA as of Q4 2022.

Churchill Management reported no remaining Privia Health position as of Q4 2022 after selling out during the quarter.
Churchill Management sold 89,714 Privia Health shares in Q4 2022, an estimated $3.06M.
Churchill Management first reported a position in Privia Health in Q3 2022 and held it in 1 quarter.
Churchill Management's Privia Health position peaked at $3.06M in Q3 2022.
192 funds tracked by Wall St. Rank held Privia Health as of Q4 2022.

Based on Churchill Management's 13F filing for Q4 2022, filed 10 Jan 2023.